Explore

Trendline Trendline
Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment
Trendline Trendline
Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer

Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer

Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
SB Nation SB Nation
Who is visiting the Badgers this weekend?

Who is visiting the Badgers this weekend?

The Badgers have 19 recruits coming to campus this weekend.
Trendline Trendline
Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026
Trendline Trendline
Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies
Trendline Trendline
Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors
Trendline Trendline
Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting

Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting

Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting
Trendline Trendline
Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies
Trendline Trendline
Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results

Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results

Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results
Trendline Trendline
IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances
SB Nation SB Nation
Monday Dots: Don’t Look Back in Anger

Monday Dots: Don’t Look Back in Anger

You don’t know what you’re missing, nowAny little Dots that you knowEverything that’s small has to growAnd it’s gonna grow, push push, yeah